ArticleJournal of clinical medicine2023

Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn's Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study.

Ayal Hirsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.